CRYSTAL WHITEHOUSE: Open Payments
NPI 1801346259 · OWENSBORO, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$883 in 38 payments from 9 companies in 2025. Trend: 2023 $331 · 2024 $481 · 2025 $883
Food & beverage: $882Education: $1
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 4 | $207 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $206 |
| Vanda Pharmaceuticals Inc. | 6 | $184 |
| Supernus Pharmaceuticals, Inc. | 11 | $148 |
| Tris Pharma Inc | 1 | $48 |
| Corium, LLC | 4 | $38 |
| Boston Scientific Corporation | 1 | $21 |
| Lundbeck LLC | 1 | $17 |
| ABBVIE INC. | 1 | $14 |
Products named: COBENFY, CAPLYTA, FANAPT, Qelbree, Dyanavel XR, Azstarys, BodyGuardian, REXULTI.
Industry payments across KY — which companies pay providers there.
